AMD's Ryzen 7040U chips promise speedier graphics for thin-and-light laptops
Ryzen 7040U processors that it claims can outrun the competition, particularly for gamers who may need to be content with integrated graphics. They all tout RDNA 3-based Radeon 700M GPUs that tout the enhancements seen on desktop video cards. A Ryzen 7 with the Radeon 780M runs between 30 percent to 139 percent faster than an equivalent Intel 13th-gen Core i7 P-series chip, AMD claims.
AMD also believes the Ryzen 7040U line offers better raw computing power than rivals. The Zen 4 architecture is said to deliver between 29 percent to 128 percent better app performance than not just the Core i7, but 5 percent to 75 percent over the M2 found in Apple's. AMD is relying on synthetic benchmarks to make the claim and is testing its highest-end Ryzen 7 part, but that may be worth considering if you plan to edit videos or juggle multiple productivity apps.
The new hardware also brings Ryzen AI acceleration to offload some work from the chip's main compute units. AMD also boasts of improved efficiency to provide the"longest possible time" on battery power, although it doesn't provide estimates. That's likely to vary based on the CPU model and exact laptop.
The initial lineup includes four processors. The Ryzen 3 7440U is aimed at the entry level with four cores, eight processing threads, a base 3GHz clock speed and 12MB of cache. At the mid-range, the Ryzen 5 7540U uses six cores, 12 threads, a baseline 3.2GHz speed and 22MB of cache. The Ryzen 5 7640U is slightly faster with Ryzen AI support, a 3.5GHz clock . The top-end Ryzen 7 7840U includes eight cores, 16 threads, Ryzen AI, a 3.3GHz starting clock and 24MB of cache.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
AMD makes Ryzen 7840U official, claims it can beat Apple M2But the charts are pretty vague.
Read more »
Uncontrolled Wet AMD: Drug Switch Can Mute Disease ActivitySome patients with uncontrolled neovascular age-related macular degeneration achieved a reduction in disease activity and gains in visual acuity after switching to the biologic agent brolucizumab, according to a new study presented ARVO2023. nAMD
Read more »
AMD faces doubts after Intel earnings: Is the bar set too high?Advanced Micro Devices Inc. won't have the dismally low expectations that Intel Corp. had to clear last week when it reports its results.
Read more »
AMD revenue drops 9% as PC chip sales decline sharplyAMD's report comes as the PC industry is in a deep slump, with shipments dropping 30% in the first quarter, according to IDC.
Read more »
AMD forecasts second quarter below estimates with slow chip demandAdvanced Micro Devices forecast second-quarter revenue below estimates on Tuesday, showing the chip firms will continue to face challenges as PC sales and the data center market remain weak.
Read more »